These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9603922)

  • 1. A soluble major histocompatibility complex class I peptide-binding platform undergoes a conformational change in response to peptide epitopes.
    Rigney E; Kojima M; Glithero A; Elliott T
    J Biol Chem; 1998 Jun; 273(23):14200-4. PubMed ID: 9603922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for the peptide-induced conformational change of free major histocompatibility complex class I heavy chains.
    Elliott T; Elvin J; Cerundolo V; Allen H; Townsend A
    Eur J Immunol; 1992 Aug; 22(8):2085-91. PubMed ID: 1639105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer.
    Bouvier M; Wiley DC
    Nat Struct Biol; 1998 May; 5(5):377-84. PubMed ID: 9587000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for conformational dynamics in major histocompatibility complex class I molecules.
    van Hateren A; Anderson M; Bailey A; Werner JM; Skipp P; Elliott T
    J Biol Chem; 2017 Dec; 292(49):20255-20269. PubMed ID: 29021251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short peptides assist the folding of free class I heavy chains in solution.
    Elliott T; Cerundolo V; Townsend A
    Eur J Immunol; 1992 Dec; 22(12):3121-5. PubMed ID: 1280223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors.
    Walter JB; Garboczi DN; Fan QR; Zhou X; Walker BD; Eisen HN
    J Immunol Methods; 1998 May; 214(1-2):41-50. PubMed ID: 9692857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
    Smith JD; Solheim JC; Carreno BM; Hansen TH
    Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-induced conformational change of the class I heavy chain.
    Elliott T; Cerundolo V; Elvin J; Townsend A
    Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding.
    Springer S; Doring K; Skipper JC; Townsend AR; Cerundolo V
    Biochemistry; 1998 Mar; 37(9):3001-12. PubMed ID: 9485452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.
    Wu Y; Zhang N; Hashimoto K; Xia C; Dijkstra JM
    Front Immunol; 2021; 12():621153. PubMed ID: 34194421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.
    Bluestone JA; Jameson S; Miller S; Dick R
    J Exp Med; 1992 Dec; 176(6):1757-61. PubMed ID: 1460430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries.
    Stevens J; Wiesmüller KH; Barker PJ; Walden P; Butcher GW; Joly E
    J Biol Chem; 1998 Jan; 273(5):2874-84. PubMed ID: 9446598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.
    Zacharias M; Springer S
    Biophys J; 2004 Oct; 87(4):2203-14. PubMed ID: 15454423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
    Jones LL; Brophy SE; Bankovich AJ; Colf LA; Hanick NA; Garcia KC; Kranz DM
    J Biol Chem; 2006 Sep; 281(35):25734-44. PubMed ID: 16815841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A region of conformational variability outside the peptide-binding site of a class I MHC molecule.
    Kuhns ST; Pease LR
    J Immunol; 1998 Dec; 161(12):6745-50. PubMed ID: 9862704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status.
    Wearsch PA; Jakob CA; Vallin A; Dwek RA; Rudd PM; Cresswell P
    J Biol Chem; 2004 Jun; 279(24):25112-21. PubMed ID: 15056662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ab initio association with beta 2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding.
    Wang H; Capps GG; Robinson BE; Zúñiga MC
    J Biol Chem; 1994 Sep; 269(35):22276-81. PubMed ID: 8071354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.
    Corr M; Boyd LF; Frankel SR; Kozlowski S; Padlan EA; Margulies DH
    J Exp Med; 1992 Dec; 176(6):1681-92. PubMed ID: 1281216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.